IVAX GETS FINAL FDA APPROVAL FOR TAMOXIFEN ANDA.
IVAX currently has 37 ANDAs and one tentative approval pending at the FDA. The company is continuing its aggressive filing schedule for new ANDA submissions.
IVAX Corporation, headquartered in Miami, Florida, discovers, develops, manufactures, and markets branded and brand equivalent (generic) pharmaceuticals and veterinary products in the U.S. and internationally.
For more information, call 305/575-6043
|Printer friendly Cite/link Email Feedback|
|Date:||Apr 1, 2003|
|Previous Article:||CURIS BMP-7 PROTEIN DRUG CANDIDATE ENHANCES STROKE RECOVERY.|
|Next Article:||NYMOX BEGINS PHASE I STUDIES FOR NX-1207 PROSTATE TREATMENT.|
|FDA GIVES TENTATIVE APPROVAL FOR GENERIC VERSION OF PROZAC.|
|IVAX GETS FINAL APPROVAL FOR GENERIC HYPERTENSION TABLETS.|
|IVAX GETS FINAL APPROVAL FOR METFORMIN.|